Alteration of Ceramide Synthase 6/C16-ceramide Induces Activating Transcription Factor 6-mediated Endoplasmic Reticulum (ER) Stress and Apoptosis Via Perturbation of Cellular Ca2+ and ER/Golgi Membrane Network
Overview
Authors
Affiliations
Mechanisms that regulate endoplasmic reticulum (ER) stress-induced apoptosis in cancer cells remain enigmatic. Recent data suggest that ceramide synthase1-6 (CerS1-6)-generated ceramides, containing different fatty acid chain lengths, might exhibit distinct and opposing functions, such as apoptosis versus survival in a context-dependent manner. Here, we investigated the mechanisms involved in the activation of one of the major ER stress response proteins, ATF-6, and subsequent apoptosis by alterations of CerS6/C(16)-ceramide. Induction of wild type (WT), but not the catalytically inactive mutant CerS6, increased tumor growth in SCID mice, whereas siRNA-mediated knockdown of CerS6 induced ATF-6 activation and apoptosis in multiple human cancer cells. Down-regulation of CerS6/C(16)-ceramide, and not its further metabolism to glucosylceramide or sphingomyelin, activated ATF-6 upon treatment with ER stress inducers tunicamycin or SAHA (suberoylanilide hydroxamic acid). Induction of WT-CerS6 expression, but not its mutant, or ectopic expression of the dominant-negative mutant form of ATF-6 protected cells from apoptosis in response to CerS6 knockdown and tunicamycin or SAHA treatment. Mechanistically, ATF-6 activation was regulated by a concerted two-step process involving the release of Ca(2+) from the ER stores ([Ca(2+)](ER)), which resulted in the fragmentation of Golgi membranes in response to CerS6/C(16)-ceramide alteration. This resulted in the accumulation of pro-ATF-6 in the disrupted ER/Golgi membrane network, where pro-ATF6 is activated. Accordingly, ectopic expression of a Ca(2+) chelator calbindin prevented the Golgi fragmentation, ATF-6 activation, and apoptosis in response to CerS6/C(16)-ceramide down-regulation. Overall, these data suggest a novel mechanism of how CerS6/C(16)-ceramide alteration activates ATF6 and induces ER-stress-mediated apoptosis in squamous cell carcinomas.
Camacho-Morales A, Noriega L, Sanchez-Garcia A, Torre-Villalvazo I, Vazquez-Manjarrez N, Maldonado-Ruiz R Heliyon. 2024; 10(20):e39206.
PMID: 39640709 PMC: 11620212. DOI: 10.1016/j.heliyon.2024.e39206.
Glycosylation of ceramide synthase 6 is required for its activity.
Straus A, Mavodza G, Senkal C J Lipid Res. 2024; 66(1):100715.
PMID: 39608570 PMC: 11732463. DOI: 10.1016/j.jlr.2024.100715.
Amatruda M, Marechal D, Gacias M, Wentling M, Turpin-Nolan S, Morstein J Glia. 2024; 73(2):271-290.
PMID: 39489703 PMC: 11662985. DOI: 10.1002/glia.24631.
Jin Y, Cui Y, Xu Y, Chen J, Zhang X, Wang X J Inflamm Res. 2024; 17:7261-7274.
PMID: 39429850 PMC: 11486677. DOI: 10.2147/JIR.S476276.
The diverse roles of sphingolipids in inflammatory bowel disease.
Doll C, Snider A FASEB J. 2024; 38(13):e23777.
PMID: 38934445 PMC: 467036. DOI: 10.1096/fj.202400830R.